# Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor

> **NCT02430233** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 129 (actual)

## Conditions studied

- Preterm Labor

## Interventions

- **DRUG:** micronized progesterone 400 mg (Utrogestan)

## Key facts

- **NCT ID:** NCT02430233
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-19
- **Primary completion:** 2023-02-27
- **Final completion:** 2023-02-27
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02430233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02430233, "Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02430233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*